Should Pharma Replace the Term “KOL”?

Pharmaguy interviews Sanjay Singhvi, Director, System Analytic, about KOL terminology and the research his company conducted around it with KOLs and pharmaceutical executives.

Topics/Questions discussed include:

Are pharmaceutical companies still using the term KOL?Why the interest in changing the terminology?Is this a divisive/controversial issue?Is this a superficial change or reflective of something deeper?What about "KOLs" themselves? What do they think?How does all this affect vendors/service providers? E.g. What are they searching for in Google - still searching for "KOL Mapping"?!